BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/20/2026 8:11:58 AM | Browse: 7 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 119152
Country China
Category Immunology
Manuscript Type Correspondence
Article Title Letter to the Editor: Reovirus as an immunomodulatory adjuvant in KRAS-mutant colorectal cancer - translational insights and future directions
Manuscript Source Invited Manuscript
All Author List Xin-Lei Zhou, Fan Chen and Kai-Bo Guo
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Zhejiang Province, China ZCLQ24H2901
National Natural Science Foundation of China 82405093
Medical and Health Technology Program of Zhejiang Province, China 2024KY1328
Traditional Chinese Medicine Science and Technology Program of Zhejiang Province, China 2024ZL712
Corresponding Author Kai-Bo Guo, MD, Department of Oncology, Affiliated Hangzhou First People's Hospital , School of Medicine, Westlake University, No. 261 Huansha Road, Hangzhou 310006, Zhejiang Province, China. guokaibo@zcmu.edu.cn
Key Words Reovirus; KRAS mutation; Immune modulation; Tumor microenvironment; Metastatic colorectal cancer; Signaling pathway; Cytokine
Core Tip This study discussed that reovirus affects gene expression and cytokine secretion by regulating phosphatidylinositol 3-kinase/protein kinase B and other signaling pathways, thereby regulating the immune system and ultimately exerting an anti-KRAS mutant colon cancer effect. The letter proposes to more accurately elucidate the local immune regulation mechanism of reovirus through large-scale, multi-center randomized controlled trials, combined with tumor microenvironment analysis and combined immunotherapy design, and enrich experimental analysis methods, laying a good foundation for clinical application of reovirus.
Citation Zhou XL, Chen F, Guo KB. Letter to the Editor: Reovirus as an immunomodulatory adjuvant in KRAS-mutant colorectal cancer - translational insights and future directions. World J Clin Oncol 2026; In press
Received
2026-01-22 02:04
Peer-Review Started
2026-01-22 02:05
First Decision by Editorial Office Director
2026-02-25 07:57
Return for Revision
2026-02-25 07:57
Revised
2026-03-10 15:37
Publication Fee Transferred
Second Decision by Editor
2026-04-20 02:54
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-20 08:11
Articles in Press
2026-04-20 08:11
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com